Concepedia

Zhiyang Cheng

ZC

Statistics

Publications

3

Citations

80

H-Index

3

Active since

2021

Affiliations

East China Normal University(Current)

Chinese Academy of Sciences

Shanghai Institute of Materia Medica

Zhiyang Cheng is an author at East China Normal University specializing in prodrug design, pharmacy, and anticancer prodrug design.

ORCID

Publications per year

2021–2024

3

Publications

3

SN38-based albumin-binding prodrug for efficient targeted cancer chemotherapy

Ying Huang, Lei Wang, Zhiyang Cheng et al. · Journal of Controlled Release · 2021 · 40 citations

, , +14

A camptothecin-based, albumin-binding prodrug enhances efficacy and safety in vivo

Zhiyang Cheng, Ying Huang, Qianqian Shen et al. · European Journal of Medicinal Chemistry · 2021 · 22 citations

, , +8

Evaluation of Double Self-Immolative Linker-Based Antibody–Drug Conjugate FDA022-BB05 with Enhanced Therapeutic Potential

Yifan Zhang, Lei Wang, Xuemei Cao et al. · Journal of Medicinal Chemistry · 2024 · 18 citations

, , +17

1–3 of 3